Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 564

1.

Comparison of measured GFR, serum creatinine, cystatin C, and beta-trace protein to predict ESRD in African Americans with hypertensive CKD.

Bhavsar NA, Appel LJ, Kusek JW, Contreras G, Bakris G, Coresh J, Astor BC; AASK Study Group.

Am J Kidney Dis. 2011 Dec;58(6):886-93. doi: 10.1053/j.ajkd.2011.07.018. Epub 2011 Sep 22.

2.

Filtration markers as predictors of ESRD and mortality in Southwestern American Indians with type 2 diabetes.

Foster MC, Inker LA, Hsu CY, Eckfeldt JH, Levey AS, Pavkov ME, Myers BD, Bennett PH, Kimmel PL, Vasan RS, Coresh J, Nelson RG; CKD Biomarkers Consortium.

Am J Kidney Dis. 2015 Jul;66(1):75-83. doi: 10.1053/j.ajkd.2015.01.013. Epub 2015 Mar 12.

3.

Novel markers of kidney function as predictors of ESRD, cardiovascular disease, and mortality in the general population.

Astor BC, Shafi T, Hoogeveen RC, Matsushita K, Ballantyne CM, Inker LA, Coresh J.

Am J Kidney Dis. 2012 May;59(5):653-62. doi: 10.1053/j.ajkd.2011.11.042. Epub 2012 Feb 4.

4.

GFR Estimation Using β-Trace Protein and β2-Microglobulin in CKD.

Inker LA, Tighiouart H, Coresh J, Foster MC, Anderson AH, Beck GJ, Contreras G, Greene T, Karger AB, Kusek JW, Lash J, Lewis J, Schelling JR, Navaneethan SD, Sondheimer J, Shafi T, Levey AS.

Am J Kidney Dis. 2016 Jan;67(1):40-8. doi: 10.1053/j.ajkd.2015.07.025. Epub 2015 Sep 9.

5.

Serum β-Trace Protein and β2-Microglobulin as Predictors of ESRD, Mortality, and Cardiovascular Disease in Adults With CKD in the Chronic Renal Insufficiency Cohort (CRIC) Study.

Foster MC, Coresh J, Hsu CY, Xie D, Levey AS, Nelson RG, Eckfeldt JH, Vasan RS, Kimmel PL, Schelling J, Simonson M, Sondheimer JH, Anderson AH, Akkina S, Feldman HI, Kusek JW, Ojo AO, Inker LA; CKD Biomarker Consortium and the CRIC Study Investigators.

Am J Kidney Dis. 2016 Jul;68(1):68-76. doi: 10.1053/j.ajkd.2016.01.015. Epub 2016 Mar 3.

6.

Non-GFR Determinants of Low-Molecular-Weight Serum Protein Filtration Markers in CKD.

Liu X, Foster MC, Tighiouart H, Anderson AH, Beck GJ, Contreras G, Coresh J, Eckfeldt JH, Feldman HI, Greene T, Hamm LL, He J, Horwitz E, Lewis J, Ricardo AC, Shou H, Townsend RR, Weir MR, Inker LA, Levey AS; CRIC (Chronic Renal Insufficiency Cohort) Study Investigators.

Am J Kidney Dis. 2016 Dec;68(6):892-900. doi: 10.1053/j.ajkd.2016.07.021. Epub 2016 Sep 20.

PMID:
27663042
7.

Serum creatinine, cystatin C, and beta-trace protein in diagnostic staging and predicting progression of primary nondiabetic chronic kidney disease.

Spanaus KS, Kollerits B, Ritz E, Hersberger M, Kronenberg F, von Eckardstein A; Mild and Moderate Kidney Disease (MMKD) Study Group.

Clin Chem. 2010 May;56(5):740-9. doi: 10.1373/clinchem.2009.138826. Epub 2010 Mar 11.

8.

Novel filtration markers as predictors of all-cause and cardiovascular mortality in US adults.

Foster MC, Inker LA, Levey AS, Selvin E, Eckfeldt J, Juraschek SP, Coresh J; CKD Biomarkers Consortium.

Am J Kidney Dis. 2013 Jul;62(1):42-51. doi: 10.1053/j.ajkd.2013.01.016. Epub 2013 Mar 19.

9.

Comparison of serum cystatin C, serum creatinine, measured GFR, and estimated GFR to assess the risk of kidney failure in American Indians with diabetic nephropathy.

Pavkov ME, Knowler WC, Hanson RL, Williams DE, Lemley KV, Myers BD, Nelson RG.

Am J Kidney Dis. 2013 Jul;62(1):33-41. doi: 10.1053/j.ajkd.2012.11.044. Epub 2013 Jan 21.

10.

β-trace protein and cystatin C as predictors of long-term outcomes in patients with acute heart failure.

Manzano-Fernández S, Januzzi JL Jr, Boronat-Garcia M, Bonaque-González JC, Truong QA, Pastor-Pérez FJ, Muñoz-Esparza C, Pastor P, Albaladejo-Otón MD, Casas T, Valdés M, Pascual-Figal DA.

J Am Coll Cardiol. 2011 Feb 15;57(7):849-58. doi: 10.1016/j.jacc.2010.08.644.

11.

What is the goal with endogenous filtration markers--estimation of GFR or prediction of kidney outcomes?

Rule AD, Bailey KR, Turner ST.

Am J Kidney Dis. 2011 Dec;58(6):865-7. doi: 10.1053/j.ajkd.2011.10.001. No abstract available.

PMID:
22099567
12.

Effect of clinical variables and immunosuppression on serum cystatin C and beta-trace protein in kidney transplant recipients.

White CA, Akbari A, Doucette S, Fergusson D, Ramsay T, Hussain N, Dinh L, Filler G, Lepage N, Knoll GA.

Am J Kidney Dis. 2009 Nov;54(5):922-30. doi: 10.1053/j.ajkd.2009.06.003. Epub 2009 Jul 19.

PMID:
19619919
13.

Filtration markers may have prognostic value independent of glomerular filtration rate.

Tangri N, Inker LA, Tighiouart H, Sorensen E, Menon V, Beck G, Shlipak M, Coresh J, Levey AS, Sarnak MJ.

J Am Soc Nephrol. 2012 Feb;23(2):351-9. doi: 10.1681/ASN.2011070663. Epub 2011 Dec 15.

14.

Usefulness of β-trace protein and cystatin C for the prediction of mortality in non ST segment elevation acute coronary syndromes.

Manzano-Fernández S, López-Cuenca A, Januzzi JL, Parra-Pallares S, Mateo-Martínez A, Sánchez-Martínez M, Pérez-Berbel P, Orenes-Piñero E, Romero-Aniorte AI, Avilés-Plaza F, Valdés-Chavarri M, Marín F.

Am J Cardiol. 2012 Nov 1;110(9):1240-8. doi: 10.1016/j.amjcard.2012.06.027. Epub 2012 Jul 19.

PMID:
22818840
15.

Change in novel filtration markers and risk of ESRD.

Rebholz CM, Grams ME, Matsushita K, Selvin E, Coresh J.

Am J Kidney Dis. 2015 Jul;66(1):47-54. doi: 10.1053/j.ajkd.2014.11.009. Epub 2014 Dec 24.

16.

Risk of ESRD and Mortality Associated With Change in Filtration Markers.

Rebholz CM, Inker LA, Chen Y, Liang M, Foster MC, Eckfeldt JH, Kimmel PL, Vasan RS, Feldman HI, Sarnak MJ, Hsu CY, Levey AS, Coresh J; Chronic Kidney Disease Biomarkers Consortium.

Am J Kidney Dis. 2017 Jun 22. pii: S0272-6386(17)30733-3. doi: 10.1053/j.ajkd.2017.04.025. [Epub ahead of print]

PMID:
28648303
17.

Detection of chronic kidney disease with creatinine, cystatin C, and urine albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortality.

Peralta CA, Shlipak MG, Judd S, Cushman M, McClellan W, Zakai NA, Safford MM, Zhang X, Muntner P, Warnock D.

JAMA. 2011 Apr 20;305(15):1545-52. doi: 10.1001/jama.2011.468. Epub 2011 Apr 11.

18.

Association of kidney function and albuminuria with prevalent and incident hypertension: the Atherosclerosis Risk in Communities (ARIC) study.

Huang M, Matsushita K, Sang Y, Ballew SH, Astor BC, Coresh J.

Am J Kidney Dis. 2015 Jan;65(1):58-66. doi: 10.1053/j.ajkd.2014.06.025. Epub 2014 Aug 21.

19.

The value of estimated GFR in comparison to measured GFR for the assessment of renal function in adult patients with Fabry disease.

Rombach SM, Baas MC, ten Berge IJ, Krediet RT, Bemelman FJ, Hollak CE.

Nephrol Dial Transplant. 2010 Aug;25(8):2549-56. doi: 10.1093/ndt/gfq108. Epub 2010 Mar 9.

PMID:
20215390
20.

Serum and urinary markers of early impairment of GFR in chronic kidney disease patients: diagnostic accuracy of urinary β-trace protein.

Donadio C.

Am J Physiol Renal Physiol. 2010 Dec;299(6):F1407-23. doi: 10.1152/ajprenal.00507.2009. Epub 2010 Sep 15.

Supplemental Content

Support Center